August 21, 2002
1 min read
Save

VEGF, endostatin correlated with angiogenesis in DR, study finds

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

TOKYO — Both vascular endothelial growth factor and endostatin are correlated with the severity of diabetic retinopathy, according to a study here. The mechanisms of these substances may be good candidates for development of therapeutic agents for proliferative diabetic retinopathy, the study authors suggest.

Researchers here studied 159 eyes of 120 patients with diabetes to determine concentrations of vascular endothelial growth factor (VEGF) and endostatin in vitreous fluid and aqueous humor.

The concentrations of VEGF in aqueous humor and vitreous fluid were significantly correlated with the severity of diabetic retinopathy (DR), as were the concentrations of endostatin in aqueous humor and vitreous fluid. Concentrations of VEGF and endostatin in the eyes were not correlated with those in the plasma.

The study is published in the August issue of Archives of Ophthalmology.